TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas.
about
Vitamin D and Inflammatory Cytokines in Healthy and Preeclamptic PregnanciesCytokines as key players in the pathophysiology of preeclampsiaElucidating immune mechanisms causing hypertension during pregnancyIncreased apoptosis in first trimester extravillous trophoblasts from pregnancies at higher risk of developing preeclampsiaTransforming growth factor-beta 1 does not relate to hypertension in pre-eclampsia.Down-regulation of TIMP3 leads to increase in TACE expression and TNFα production by placental trophoblast cells.Role of peroxiredoxin III in the pathogenesis of pre-eclampsia as evidenced in mice.Angiotensin receptor agonistic autoantibody-mediated tumor necrosis factor-alpha induction contributes to increased soluble endoglin production in preeclampsiaMonocytes and macrophages in pregnancy and pre-eclampsiaInhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies.Regulation of proinflammatory cytokines in human lung epithelial cells infected with Mycoplasma pneumoniae.Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium.Induction of proinflammatory cytokines in human lung epithelial cells during Chlamydia pneumoniae infectionPro-inflammatory profile of preeclamptic placental mesenchymal stromal cells: new insights into the etiopathogenesis of preeclampsia.Maternal circulating TNF-alpha levels are highly correlated with IL-10 levels, but not IL-6 and IL-8 levels, in women with pre-eclampsia.Maternal Schistosomiasis japonica is associated with maternal, placental, and fetal inflammation.Maternal tumor necrosis factor receptor 2 gene variants associated with pre-eclampsia in Tunisian women.Regulation of pregnancy-associated plasma protein A2 (PAPPA2) in a human placental trophoblast cell line (BeWo).Regulation of monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha and interleukin-1beta in first trimester human decidual cells: implications for preeclampsia.Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia.IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate?Endoplasmic reticulum stress in the pathogenesis of early-onset pre-eclampsia.Altered interleukin-6 receptor, IL-6R and gp130, production and expression and decreased SOCS-3 expression in placentas from women with pre-eclampsia.Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia.ADAM17 regulates TNFα production by placental trophoblasts.Nicotine inhibits cytokine production by placenta cells via NFkappaB: potential role in pregnancy-induced hypertension.Leukocytes of pregnant women with small-for-gestational age neonates have a different phenotypic and metabolic activity from those of women with preeclampsia.Increased risk for the development of preeclampsia in obese pregnancies: weighing in on the mechanisms.Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnanciesActivation of NF-κB in placentas of women with preeclampsia.CXCL10/IP-10: a missing link between inflammation and anti-angiogenesis in preeclampsia?Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction.Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia.The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia.Endothelial dysfunction. An important mediator in the pathophysiology of hypertension during pre-eclampsia.IL-27 activates human trophoblasts to express IP-10 and IL-6: implications in the immunopathophysiology of preeclampsia.Tumor necrosis factor-alpha polymorphism at position -238 in preeclampsia.Immunologic characteristics of preeclampsia, a comprehensive review.The pathophysiology of preeclampsia involves altered levels of angiogenic factors promoted by hypoxia and autoantibody-mediated mechanisms.Placenta-derived angiogenic proteins and their contribution to the pathogenesis of preeclampsia.
P2860
Q26801481-6B4EDC14-7AB1-40E5-A291-49E7FB49A8B3Q26830707-DCD85443-4FB4-4C01-895E-C3CEBA732AFBQ26852668-52B6AC13-E0B8-4878-A226-984F64B4FD6EQ30479679-1A25C24E-F18D-48DE-A8F8-6F3ABF4F18F7Q30860125-9AFC0B3A-FB95-4BB5-A69C-9D31FC0621AEQ33596885-11BB16FA-69F5-4345-BD88-AA8FC9CE637FQ33716927-E05CB79C-414D-4C3B-88D1-A614B76DB81EQ33748650-17942887-DCDE-45A3-BD3A-606896518735Q33820908-B7AC4AE9-4935-404E-BB2A-D287BF2A4216Q33853208-E0C0D258-F792-4F52-B1EB-3A2CF9DF7046Q34125093-13DB4735-B963-4E5F-A7DA-087EFEBB3350Q34280666-076A2067-7DD1-4E89-A975-EEDE477DB93CQ34581245-A1F0B6A4-CC6D-4036-9B6F-7F16E553ED49Q34635145-5352501D-1876-409A-B6E6-DCD3A55DCBFBQ34707726-96EF7F73-208E-431A-9E5A-C5F303066153Q34739827-B1E21F93-8D85-4087-96F0-0E03E9C85941Q34782944-884F070C-C0E5-461E-B021-FBABAAEAC4A9Q34988844-010315C8-E76E-4799-BDDA-FA8008A1FE49Q35087963-A79D2C9D-752A-44E3-8FAF-297822A2DE65Q35096089-ADF52E44-F377-487D-900B-F20D40EAE802Q35581520-15D1FEA5-D40B-41CB-BC14-656120EA62B4Q35655232-14771C4B-F55C-4D69-962E-7CB1224D2B06Q35738082-E6377F9D-DE91-423C-9242-8CBC61D03FD0Q35793389-E38738C9-09C0-4085-A21D-D3398EDD546FQ35988831-6021D921-4F43-4C1D-A55D-28CC46B1C37FQ35995193-3FAC4C64-834C-42B2-87A3-8ED2BBC543CBQ36185268-8D95E403-93FF-4218-8F5D-D412E339308AQ36422496-A512A4A7-949A-47A8-A3D6-CD105CE7C830Q36512063-CAD96D23-0862-4CA4-A392-B3A06693D8C5Q36525564-7207B753-C261-424A-AB04-A06488ABA248Q36676660-7BB34DF4-8F8A-4E3B-A62B-A4A1437A419AQ37022723-839C5E4C-F91D-4CCC-B72A-EF5091D9225BQ37079628-5ABBE596-1282-473A-A691-492A62FC29FEQ37088970-6EA8EBC1-D32C-4D3F-A3F2-079C45E14008Q37229246-22457FBB-9B07-4211-927E-9D489F9C2095Q37603257-DFC6521A-EF19-4254-822D-7A3034B893BBQ37660749-08EBB019-1774-4B61-BA4A-E56CF365824CQ37786350-B15A1613-AC4E-489F-A20A-D8002C4ADB01Q38014802-9A68F6D0-F3C1-4769-A4ED-9D92A2FC945AQ38272641-28A38D31-5B8A-4D1F-A3ED-BC5908BC0B5F
P2860
TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas.
@en
TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas.
@nl
type
label
TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas.
@en
TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas.
@nl
prefLabel
TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas.
@en
TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas.
@nl
P1476
TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas.
@en
P2093
P304
P356
10.1016/S0165-0378(96)00998-9
P577
1996-12-01T00:00:00Z